E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers T > Headlines for Tenders 2004 > News item
Published on 9/27/2004 in the Prospect News Convertibles Daily.

Human Genome Sciences to buy back convertibles with $200 million offering proceeds

Pittsburgh, Sept. 27 - Human Genome Sciences Inc. will use net proceeds from its offering of $200 million of new convertible subordinated notes to buy back a portion of its outstanding convertible subordinated debt from time to time, according to a company news release.

The new deal also includes a 30-day, $50 million over-allotment option.

Human Genome Sciences is based in Rockville, Md.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.